Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P McGovern

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Psychiatric Services (Washington, D.C.)|July 3, 2007
Co-occurring psychiatric and substance use disorders: a multistate feasibility study of the quadrant modelMark P McGovern, Robin E Clark, Mihail Samnaliev
Psychiatric Services (Washington, D.C.)|December 31, 2008
Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disordersRobin E Clark, Mihail Samnaliev, Mark P McGovern
Journal of Substance Abuse Treatment|November 6, 2010
The boundaries of addiction treatment services researchMark P McGovern, Elizabeth C Saunders, Martin M Vakili
Psychiatric Services (Washington, D.C.)|October 11, 2005
Future directions in preventing relapse to substance abuse among clients with severe mental illnessesRobert E Drake, Michael A Wallach, Mark P McGovern
Journal of American College Health : J of ACH|December 13, 2005
A systematic analysis of college substance use policiesLindsay M Hirschfeld, Karin L Edwardson, Mark P McGovern
BMC Family Practice|November 16, 2019
Attitudes of primary care physicians toward prescribing buprenorphine: a narrative reviewDexter L Louie, Mehret T Assefa, Mark P McGovern
Psychiatric Services (Washington, D.C.)|October 11, 2005
Relapse of substance use disorder and its prevention among persons with co-occurring disordersMark P McGovern, Bonnie R Wrisley, Robert E Drake
Substance Use & Addiction Journal|May 10, 2026
Anxiety, Bipolar, Depressive, and Schizophrenia Diagnoses Among Patients Receiving Addiction Treatment in the United States, 2006-2022: A Descriptive StudyOrrin D Ware, David A Fiellin, Mark P McGovern
Drug and Alcohol Dependence|May 30, 2021
A mapping review of NIDA-funded implementation research studies on treatments for opioid and/or stimulant use disordersHannah Cheng, Hélène Chokron Garneau, Mina Yuan, et al.
Substance Use & Misuse|June 13, 2003
Gender of physicians with substance use disorders: clinical characteristics, treatment utilization, and post-treatment functioningMark P McGovern, Daniel H Angres, Matthew Shaw, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Psychiatric Services (Washington, D.C.)|July 3, 2007
Co-occurring psychiatric and substance use disorders: a multistate feasibility study of the quadrant modelMark P McGovern, Robin E Clark, Mihail Samnaliev
Psychiatric Services (Washington, D.C.)|December 31, 2008
Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disordersRobin E Clark, Mihail Samnaliev, Mark P McGovern
Journal of Substance Abuse Treatment|November 6, 2010
The boundaries of addiction treatment services researchMark P McGovern, Elizabeth C Saunders, Martin M Vakili
Psychiatric Services (Washington, D.C.)|October 11, 2005
Future directions in preventing relapse to substance abuse among clients with severe mental illnessesRobert E Drake, Michael A Wallach, Mark P McGovern
Journal of American College Health : J of ACH|December 13, 2005
A systematic analysis of college substance use policiesLindsay M Hirschfeld, Karin L Edwardson, Mark P McGovern
BMC Family Practice|November 16, 2019
Attitudes of primary care physicians toward prescribing buprenorphine: a narrative reviewDexter L Louie, Mehret T Assefa, Mark P McGovern
Psychiatric Services (Washington, D.C.)|October 11, 2005
Relapse of substance use disorder and its prevention among persons with co-occurring disordersMark P McGovern, Bonnie R Wrisley, Robert E Drake
Substance Use & Addiction Journal|May 10, 2026
Anxiety, Bipolar, Depressive, and Schizophrenia Diagnoses Among Patients Receiving Addiction Treatment in the United States, 2006-2022: A Descriptive StudyOrrin D Ware, David A Fiellin, Mark P McGovern
Drug and Alcohol Dependence|May 30, 2021
A mapping review of NIDA-funded implementation research studies on treatments for opioid and/or stimulant use disordersHannah Cheng, Hélène Chokron Garneau, Mina Yuan, et al.
Substance Use & Misuse|June 13, 2003
Gender of physicians with substance use disorders: clinical characteristics, treatment utilization, and post-treatment functioningMark P McGovern, Daniel H Angres, Matthew Shaw, et al.
Pageof 7